Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Anyone else just assume
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(948)
•••
Comment by Nailbiter2on Sep 22, 2024 8:02pm
44 Views
Post# 36235690

RE:RE:RE:RE:RE:RE:Anyone else just assume

RE:RE:RE:RE:RE:RE:Anyone else just assume

IainCaimbeul wrote: Ah a picture of the shoulder flash of nailbiter1/2's former unit when he was in the zombie brigade.

Was it before he TRANsitioned from merely being ka reep y to his current status of so she oh paath.

No writing skills, needs pictures. We should create a fund to buy it a new box of crayons hoping it doesn't eat them all on the first day. Don't forget to share with jb85, he really likes the shape of them as do you.



Nailbiter2 wrote:

IainCaimbeul wrote: Sorry, can't help you there as I am permanently banned on several particular stock sites.

In my dealings with the staff/monitors on CEO  I have found them to be the thickest, most intransigent, out of touch group I may have ever dealt with anywhere. Total waste of time. 

You lodge a complaint, they copy and paste your complaint back to you in an email with NO resolution.

Jonnyboy85 wrote: Tell you what, get me unblocked on ceo and I'll reconsider throwing you in with their lot.








<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities